Artificial intelligence based techniques for brain tumor analysis: A systematic review.

Artif Intell MedMay 30, 2026 (epub)

Oluwabukola G Adegboro, Julia Dietlmeier, Noel E O'Connor et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review evaluates artificial intelligence techniques for brain tumor analysis, focusing on segmentation and classification methods. Out of 3950 sourced papers, 101 met the inclusion criteria. The review highlights a lack of fully adopted AI methods in clinical practice and identifies a significant research gap in weakly-supervised segmentation approaches.

Key findings

  • Only 101 out of 3950 sourced papers were selected for review.
  • No AI methods for brain tumor analysis have been fully adopted in clinical practice.
  • Only four articles on Explainable AI (XAI) were identified in the review.
  • The review highlights a research gap in weakly-supervised brain tumor segmentation.

Why it matters

Timely diagnosis of brain tumors is crucial for improving patient outcomes and reducing treatment costs. Understanding the current state of AI techniques can guide future research and clinical applications.

Source

Published in Artif Intell Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.